-
Navigating the ethical implications of immunoglobulin replacement therapy during pregnancy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-04-07 Timothy M. Buckey MD MBE, Kathleen E. Sullivan MD PhD
-
Hypogammaglobulinemia in 2 children with Zhu-Tokita-Takenouchi-Kim syndrome Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-04-07 Payge Van Stechelman DO, Bridget Wilson MD, Theresa A. Grebe MD, Syed Jaffery MS, Cindy S. Bauer MD
-
Why is advocacy important in allergy? Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-04-07 Melinda M. Rathkopf MD, Matt Reiter BA, Steve Dorman MD, Vinh T. Nguyen MD, J. Allen Meadows MD
-
Social media use among parents of children with food allergies Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-04-01 Aikaterini Anagnostou MD MSc PhD, Melissa Hearrell NP, Dylan Timberlake MD, Xiaofan Huang MS, Kristen A. Staggers MS, David Stukus MD
-
Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-30 Oyindamola Stephanie Kayode MD, Alla Nakonechna MD PhD, Leonard Quok Chean Siew MD PhD, Magdalena Dziadzio MD, Lucinda Kennard MD MPhil, Krzysztof Rutkowski MD, Rita Mirakian MD, Annette Wagner MD
Immediate IgE-mediated hypersensitivity reactions to polyethylene glycol (PEG) are rare. Our understanding of PEG hypersensitivity is limited. To evaluate the clinical characteristics and investigation outcomes of the largest cohort of patients with PEG allergy reported. A total of 44 patients investigated for suspected PEG allergy across 4 United Kingdom tertiary allergy centers between October 2013
-
Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-29 Pureun-Haneul Lee PhD, MinHyeok An MS, DaYeon Hwang BS, An-Soo Jang MD PhD
-
Asthma and allergy screening in elite soccer athletes: Is it worth it? Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-29 Diogo Mota MD MSc, Carla Martins MSc, Nelson Puga MD, André Moreira MD PhD
-
Sex disparities in awards granted by US allergy/immunology societies Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-29 Matthew D. Viveiros BS, Monica T. Kraft MD
-
From the pages of AllergyWatch: June 2024 Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-21 Stanley M. Fineman MD, Timothy Chow MD, Vivian Hernandez-Trujillo MD, Gerald B. Lee MD
-
Promoting prenatal penicillin allergy evaluations: A multi-year process improvement study Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-21 Lulu R. Tsao MD, Shan Wen MD, Robyn C. Lamar MD MPH, Roxanna A. Irani MD PhD, Iris M. Otani MD
-
IgG from individuals without atopy arising as mediators of a nonatopic profile in human peripheral CD4+ T cells Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-21 Fernando Roberto Machado Cunha, Beatriz Oliveira Fagundes BSc, Nicolle Rakanidis Machado BSc, Carolina Nunes França PhD, Jefferson Russo Victor PhD
-
From the pages of AllergyWatch Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-20 Stanley M. Fineman MD, Gerald B. Lee MD, Shyam R. Joshi MD, Samantha M. Knox MD
-
Association between alopecia areata and allergic diseases: An All of US database study Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-19 Erika Tsutsui MD, Austin J. Piontkowski BS, Divija Sharma BA, Nicole Ramsey MD PhD, Benjamin Ungar MD
-
Evidence for 2 clusters among patients with noneosinophilic asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-16 Halehsadat Nekoee Zahraei PhD, Florence Schleich MD PhD, Gilles Louis PhD, Sara Gerday PhD, Mare Sabbe MD, Nicolas Bougard MD, Françoise Guissard MD, Virginie Paulus MD, Monique Henket MD, Benoit Petre PhD, Anne-Françoise Donneau PhD, Renaud Louis MD PhD
Although asthma is often seen as an eosinophilic disease associated with atopy, patients with noneosinophilic asthma represent a substantial part of the population with asthma. To apply an unsupervised clustering method in a cohort of 588 patients with noneosinophilic asthma (sputum eosinophils < 3%) recruited from an asthma clinic of a secondary care center. Our cluster analysis of the whole cohort
-
Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-16 Bradley E. Chipps MD, Robert S. Zeiger MD PhD, David A. Beuther MD, Robert A. Wise MD, William McCann MD, Joan Reibman MD, Maureen George PhD RN AE-C, Ileen Gilbert MD, James M. Eudicone MS MBA, Karin S. Coyne PhD, Gale Harding MA, Kevin R. Murphy MD
National and international asthma guidelines and reports do not include control tools that combine impairment assessment with exacerbation history in 1 instrument. To analyze performance of the composite Asthma Impairment and Risk Questionnaire (AIRQ) in assessing both domains of control and predicting exacerbation risk compared with Global Initiative for Asthma (GINA) 4-question symptom control tool
-
Gut microbiome in the first 1000 days and risk for childhood food allergy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-16 Erin C. Davis PhD, Cynthia L. Monaco MD PhD, Richard Insel MD, Kirsi M. Järvinen MD PhD
To summarize recent data on the association between gut microbiome composition and food allergy (FA) in early childhood and highlight potential host-microbiome interactions that reinforce or abrogate oral tolerance. PubMed search of English-language articles related to FA, other atopic disease, and the gut microbiome in pregnancy and early childhood. Human studies published after 2015 assessing the
-
Clinical characteristics and management of pediatric egg-induced anaphylaxis: A cross-sectional study Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-16 Connor Prosty BSc, Moniah Alyasin MD, Sofianne Gabrielli MSc, Ann E. Clarke MD MSc, Judy Morris MD MSc, Jocelyn Gravel MD MSc, Rodrick Lim MD, Edmond S. Chan MD, Ran D. Goldman MD, Andrew O'Keefe MD, Jennifer Gerdts BComm, Derek K. Chu MD PhD, Julia Upton MD MPH, Elana Hochstadter MD, Jocelyn Moisan MD MSc, Adam Bretholz MD, Christine McCusker MD MSc, Xun Zhang PhD, Jennifer L.P. Protudjer PhD, Elissa
Egg is the third most common food allergy in children; however, data on pediatric egg-induced anaphylaxis are sparse. To describe the clinical characteristics, management, and outcomes of pediatric egg-induced anaphylaxis. Children presenting with anaphylaxis were recruited from 13 emergency departments as part of the Cross-Canada Anaphylaxis Registry, from which data on anaphylaxis triggered by egg
-
Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-16 Dan Huang MD PhD, Li Zhang MD PhD, Ying Liu MD PhD, Ji Wang MD PhD, Jie Zhang MD, Katherine J. Baines PhD, Gang Liu PhD, Alan Chen-Yu Hsu PhD, Fang Wang MD PhD, Zhihong Chen MD, Brian G. Oliver PhD, Min Xie MD, Ling Qin MD, Dan Liu MD PhD, Huajing Wan PhD, Fengming Luo MD PhD, Weimin Li MD PhD, Gang Wang MD PhD, Peter G. Gibson MBBS
Non-neuronal cholinergic system (NNCS) contributes to various inflammatory airway diseases. However, the role of NNCS in severe asthma (SA) remains largely unexplored. To explore airway NNCS in SA. In this prospective cohort study based on the Australasian Severe Asthma Network in a real-world setting, patients with SA (n = 52) and non-SA (n = 104) underwent clinical assessment and sputum induction
-
Bruton's tyrosine kinase inhibition for the treatment of allergic disorders Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-14 Erica V. Lin BS, Ragha V. Suresh MD, Melanie C. Dispenza MD PhD
IgE signaling through its high-affinity receptor FcεRI is central to the pathogenesis of numerous allergic disorders. Oral inhibitors of Bruton's tyrosine kinase (BTKis), which are currently Food and Drug Administration-approved for treating B cell malignancies, broadly inhibit the FcεRI pathway in human mast cells and basophils, and therefore may be effective allergen-independent therapies for a variety
-
Leveraging learning systems to improve quality and patient safety in allergen immunotherapy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-12 Alexandra E. Conway BA, Chase Rupprecht DO, Priya Bansal MD, Irene Yuan MD, Ziwei Wang MD, Marcus S. Shaker MD MS, Marylee Verdi MSN FNP-C PMHNP-BC, Joel Bradley MD
Adverse events occur in all fields of medicine, including allergy-immunology, in which allergen immunotherapy medical errors can cause significant harm. Although difficult to experience, such errors constitute opportunities for improvement. Identifying system vulnerabilities can allow resolution of latent errors before they become active problems. We review key aspects and frameworks of the medical
-
Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-12 Yijun Li PhD, Xiumei Hong PhD, Aruna Chandran MD, Corinne A. Keet MD PhD, Clary B. Clish PhD, Liming Liang PhD, Lisa P. Jacobson ScD, Xiaobin Wang MD ScD, Christine Ladd-Acosta PhD
Previous studies have linked prenatal acetaminophen use to increased asthma risk in children. However, none have explored this association while differentiating between asthma cases with and without other allergic conditions or by employing objective biomarkers to assess acetaminophen exposure. To evaluate whether the detection of acetaminophen biomarkers in cord blood is associated with the subgroups
-
Undercooked wheat allergy and new wheat allergens: A case report Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-11 Ana Luísa Pinhal MD, Borja Bartolomé PhD, Diana Silva MD PhD
-
Who are the potential patients for omalizumab for food allergy? Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-11 Hugh A. Sampson MD, J. Andrew Bird MD, David Fleischer MD, Wayne G. Shreffler MD PhD, Jonathan M. Spergel MD PhD
-
Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-11 Michele Jara DSc MPH, Ekaterina Walker MD, Stephen Tilles MD, Aikaterini Anagnostou MD PhD
-
Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-06 Do Young Gwak MD, Juliann C. Tea MD, Fariya N. Fatima BS, Jayme M. Palka PhD, Heather Lehman MD, David A. Khan MD, Hannah Zhou, Beatrice L. Wood PhD, Bruce D. Miller MD, E. Sherwood Brown MD PhD
Depression and anxiety negatively affect asthma-related quality of life (QoL). Yet, little is known regarding mood and asthma-related factors that best uniquely explain asthma-related QoL in children. This cross-sectional study evaluated the unique variance explained by caregiver and child depressive and anxiety symptom severity in child asthma-related QoL, apart from that explained by demographics
-
The association of milk and multiple food avoidance with growth parameters in infants and children Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-04 Cansin Sackesen MD, Betul Buyuktiryaki MD, Tugba Gokce MSc, Emre Gogebakan MD, Beliz Su Gundogdu MD, Sevgi Bilgic Eltan MD, Elif Karakoc-Aydiner MD, Ebru Arik Yilmaz MD, Ceren Can MD, Hilal Cengiz MD, Ozlem Unlugedik MD, Nevin Celik MD, Said Incir MD, Gul Yesiltepe Mutlu MD, Damla Yildirim MSc, Hulya Gokmen Ozel MSc, Sukru Hatun MD
Recent studies reported that strict avoidance of milk products in cow's milk allergy (CMA) affects growth and bone turnover, causing negative calcium balance and changes in bone metabolism. To investigate biochemical parameters to predict bone turnover and its relations with height and weight measurements and nutritional intake. Height, weight, and body mass index z scores were plotted for age according
-
The value of proactive management of food allergy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Roxanne Dupuis PhD, Anna Nowak-Wegrzyn MD PhD
-
Authors’ response Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Sarina Tanimoto MD PhD, Michael Kaliner MD, Richard Lockey MD, Motohiro Ebisawa MD PhD
-
Deciding noninferiority margins for non–intramuscular adrenaline delivery systems Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Parvathy Santhosh MD, Sujoy Khan FRCPath
-
Growth outcomes and food allergies in children: Study limitations Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 I-Han Cheng MD, Chin-Yuan Yii MD, Su-Boon Yong MD PhD
-
Intralymphatic immunotherapy: A status update Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Derek M. Smith MD, Kevin M. White MD
-
Route and dosage of intramuscular-alternative epinephrine delivery systems remains undetermined Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Parvathy Santhosh MD, Sujoy Khan FRCPath
-
-
The never-ending challenge of using clinical criteria to diagnose and assess severity of chronic rhinosinusitis Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Larry Borish MD
-
The 80th anniversary of atopic dermatitis in the Annals of Allergy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Donald Y.M. Leung MD PhD
-
Eicosanoids, innate immunity, and alarmins in aspirin-exacerbated respiratory disease Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Alexandra E. Conway BA, Andrew A. White MD, Larry Borish MD, Marcus Shaker MD MS, Michael W. Lee PhD
-
Safety and Efficacy Not Guaranteed: Separating Fact from Fiction Regarding Extensively Heated Egg and Milk Products: Separating fact from fiction regarding extensively heated egg and milk products Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-03-01 Aikaterini Anagnostou MD PhD, Matthew Greenhawt MD MBA MSc
-
Managing the packing list for college when it includes subcutaneous allergen immunotherapy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-26 Marcus S. Shaker MD MS, Harold Kim MD, Jedidiah A. Peterson RN, Michael Tsoulis MD MS, Dana Wallace MD
-
Effect of the Israel-Hamas war on allergy and immunology care and research Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-25 Alon Y. Hershko MD PhD, Francesca Levi-Schaffer PharmD PhD
-
Plasma microRNAs as biomarkers in hereditary angioedema Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-25 Timothy Craig DO, Kristina Richwine BS, Faoud T. Ishmael MD PhD
Hereditary angioedema (HAE) is an autosomal dominant disease with variable expression. In some families with identical genetic abnormalities, the expression can range from several attacks per month to no attacks at all. It is hypothesized that post-transcriptional gene regulation accounts for the variable expression of the disease. To identify candidate microRNAs (miRNAs) that could play a role in
-
What lessons are learned?: Our changing practice during 30 years of hereditary angioedema treatment Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Sevdenur Keskin MD, Yosif Pak DO, Jocelyn Celestin MD
-
What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder" Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Gülden Paçacı Çetin, İnsu Yılmaz
-
Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Rory Chan, Chary Duraikannu, Mohamed Jaushal Thouseef, Brian Lipworth
-
Establishment of fluorescence multi-flow cytometric immunoassay for the simultaneous quantitative detection of six allergen-sIgE antibodies Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-23 Yuanmin Sun MS, Yixian Li MS, Jian Hu MM, Xiaohui Yang MS, Bei Zhang PhD, Xueyan Wang MD, Huiqiang Li MS, Yang Yu PhD
The in vitro specific IgE (sIgE) assays now commonly used in clinical laboratories are not only time-consuming and expensive but also require many serum samples. To address these limitations, a novel fluorescent microsphere-based multiplex flow cytometric immunoassay was developed. This innovative assay enables rapid and simultaneous quantitative detection of multiple allergen-sIgE antibodies. To establish
-
Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-20 Yao Yao MS, Yujuan Yang MD, Jianwei Wang MD, Pengyi Yu BS, Jing Guo MD, Luchao Dong BS, Cai Wang BS, Pengfei Liu PhD, Yu Zhang MD PhD, Xicheng Song MD PhD
The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) with comorbid asthma remains unclear. To assess upper and lower airway unity and identify a possible common pathogenesis in CRSwNP with asthma. This study analyzed the expression of proteins and metabolites in nasal lavage fluid cells (NLFCs) and induced sputum cells (ISCs). Differentially expressed proteins and their function-related
-
Assessing meaningful change in the Asthma Impairment and Risk Questionnaire Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 William McCann MD MBA, Kevin R. Murphy MD, Robert S. Zeiger MD PhD, David A. Beuther MD PhD, Robert A. Wise MD, Joan Reibman MD, Maureen George PhD RN, Ileen Gilbert MD, James M. Eudicone MS MBA, Hitesh N. Gandhi MBBS MHA MAS, Katelyn Cutts MS, Karin S. Coyne PhD MPH, Bradley Chipps MD
The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Moreover, 7 impairment items reflect previous 2-week symptoms, and 3 risk items assess previous 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items. To evaluate the responsiveness of
-
Preparing Adolescents for Independent Asthma Management: Gaps and Opportunities Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 Suzanne Y. Ngo, Samantha Bothwell, John T. Brinton, William C. Anderson
-
Managing Anaphylaxis Away from Home Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 Theresa A. Bingemann, Marcus Shaker, Gena Heng, Matthew Greenhawt
-
Early solid introduction to prevent IgE-mediated food allergy should continue unabated while we learn more about FPIES prevalence Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-17 Linlei Ye, Stephanie C. Erdle, Elissa M. Abrams, Edmond S. Chan
-
Constant Vigilance! Managing Threats to the Skin Barrier Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-13 Vanessa Chu, Peck Y. Ong
Skin barrier defects are one of the primary causes of atopic dermatitis (AD). The basis of skin barrier defects in AD is due to a deficiency in various barrier proteins including filaggrin, involucrin, claudins, and lipids including ceramide, fatty acids and cholesterol. This review updates a more detailed lipid dysregulation in the skin barrier of AD based on recent lipidomic analysis. The clinical
-
Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor α Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-13 Taisuke Akamatsu, Toshihiro Shirai, Kohei Okawa, Keita Hirai
-
Incidence of drug-induced hypersensitivity syndrome associated with levetiracetam and clobazam is likely underreported Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-10 Nikhita R. Kichili, Alyssa Hansen, Dheeraj Kagithala, Ayezel Munoz Gonzalez, Michael Wilkerson
-
Hereditary angioedema with normal C1-inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-09 Eunice Dias de Castro MD PhD, Ana Luísa Pinhal MD, Mariana Bragança MD, João Parente Freixo MD, António Martinho MD
Hereditary angioedema with normal C1-inhibitor (HAE-nC1-INH) is a rare genetic disease with similar phenotype to HAE-C1-INH but different genetic background. Currently, 6 subtypes are recognized, based on the underlying mutations. Several aspects need further clarification. To assess clinical features of patients with genetically characterized HAE-nC1-INH from the North of Portugal. Retrospective assessment
-
Intrinsic risk factors for alpha-gal syndrome in a case-control study, 2019 to 2020 Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-08 Marissa L. Taylor, Gilbert J. Kersh, Johanna S. Salzer, Emma S. Jones, Alison M. Binder, Paige A. Armstrong, Shailesh K. Choudhary, Grace K. Commins, Claire L. Amelio, Brad J. Biggerstaff, Charles B. Beard, Lyle R. Petersen, Scott P. Commins
Alpha-gal syndrome (AGS) is an allergy to galactose-α-1,3-galactose (alpha-gal), a carbohydrate found in most mammals. Evidence indicates that AGS develops following a tick bite, and in the United States, AGS is most associated with bites from Amblyomma americanum (lone star tick); however, not all persons bitten by ticks develop clinical AGS. This study investigated intrinsic risk factors associated
-
Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-06 Yueh-Ying Han, Franziska J. Rosser, Edna Acosta-Pérez, Glorisa Canino, Juan C. Celedón
Abstract not available
-
Predominantly antibody deficiency and the association with celiac disease in Sweden Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-06 Daniel V. DiGiacomo, Bjorn Roelstraete, Benjamin Lebwohl, Peter H.R. Green, Lennart Hammarström, Jocelyn R. Farmer, Hamed Khalili, Jonas F. Ludvigsson
Predominantly antibody deficiency (PAD) is associated with noninfectious inflammatory gastrointestinal disease. Population estimates of celiac disease (CeD) risk in those with PAD are limited. To estimate population risk of PAD in individuals with CeD. We conducted a nationwide case-control study in Swedish individuals who received a diagnosis of CeD between 1997 and 2017 (n = 34,980), matched to population
-
From the pages of AllergyWatch Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-03 Stanley Fineman, Gerald B. Lee, Samantha Knox, Iris Otani
Abstract not available
-
A pathogenic role for innate-like B cells in type 2 chronic rhinosinusitis with nasal polyps Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Paul H. Dell
Abstract not available
-
A dedicated pathway to appropriate penicillin allergy examinations in pregnancy Ann. Allergy Asthma Immunol. (IF 5.9) Pub Date : 2024-02-01 Allison Ramsey
Abstract not available
-